Drug
Beta-hydroxy-butyrate
Beta-hydroxy-butyrate is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_1
2
50%
Ph not_applicable
2
50%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (50.0%)
N/A2 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_1
Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1
NCT03560323
completednot_applicable
BHB and Cognition During Exercise-Heat Stress
NCT07010666
completednot_applicable
Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity in Healthy Subjects
NCT05980858
completedphase_1
Brain Ketone Metabolism in Type 1 Diabetes
NCT02471040
Clinical Trials (4)
Showing 4 of 4 trials
NCT03560323Phase 1
Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1
NCT07010666Not Applicable
BHB and Cognition During Exercise-Heat Stress
NCT05980858Not Applicable
Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity in Healthy Subjects
NCT02471040Phase 1
Brain Ketone Metabolism in Type 1 Diabetes
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4